Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Jing Guo, Zhong-Da Liu, Yin-Ping Feng, Shui-Rong Luo & Qiao-Min Jiang. (2023) Assessment of Effective Anti-TB Regimens and Adverse Outcomes Related Risk Factors in the Elderly and Senile-Aged TB Patients. Infection and Drug Resistance 16, pages 3903-3915.
Read now
Read now
Articles from other publishers (3)
Luming Yang, Lin Wang, Qinyan Tang, Yue Liu, Chunyan Meng, Shufeng Sun, Yingzhi Chong, Yiyang Zhang & Fumin Feng. (2022) Hsa_circ_0093884 bound to RNA-binding protein RPS3 ameliorates hepatocyte inflammation in anti-tuberculosis drug-induced liver injury by competitively activating SIRT1. International Immunopharmacology 110, pages 109018.
Crossref
Crossref
Wenpei Liu, Nannan Wang, Jia Zhu, Meiling Zhang, Lihuan Lu, Hongqiu Pan, Xiaomin He, Honggang Yi & Shaowen Tang. (2022) The relationship between relative telomere length and anti-tuberculosis drug-induced hepatitis : A case-control study. Therapies.
Crossref
Crossref
Jing Sui, Wenliang Qiao, Xinrong Xiang & Youfu Luo. (2022) Epigenetic changes in Mycobacterium tuberculosis and its host provide potential targets or biomarkers for drug discovery and clinical diagnosis. Pharmacological Research 179, pages 106195.
Crossref
Crossref